CNBC — 2026-04-11#

Lead Story#

Vice President JD Vance abruptly exited peace talks in Pakistan without a deal as Iran refused U.S. demands to abandon its pursuit of nuclear weapons, keeping the fragile two-week ceasefire and the critical Strait of Hormuz shipping corridor in extreme jeopardy.

Markets & Economics#

Global energy markets remain on edge as the Iran conflict continues to throttle the Strait of Hormuz, with Brent crude hovering around $96 per barrel and retail gasoline soaring past $4 a gallon. This ongoing energy shock directly fueled a hot March inflation print, sending the Consumer Price Index (CPI) up 3.3% year-over-year. Economists warn that prolonged conflict will cause these inflationary pressures to leak into food and manufactured goods, further complicating the Federal Reserve’s interest rate path. Meanwhile, the bond market is flashing warning signs as liquidity fears over a potential private credit crisis spill over into fixed-income ETFs like BIZD and PCR, which are seeing steep discounts to net asset value amid investor redemption anxieties.

Business & Earnings#

In corporate developments, a major court victory for Berkshire Hathaway’s PacifiCorp utility could wipe out over $1 billion in prospective damages from the 2020 Oregon wildfires, serving as a significant procedural win requiring plaintiffs to individually prove liabilities. The aviation sector is actively pricing in the Middle East conflict, with Cathay Pacific cutting passenger flights through June to mitigate surging jet fuel costs. Additionally, Kodak CEO Jim Continenza reports traction in the company’s turnaround strategy, successfully riding a wave of Gen Z analog nostalgia to post a 31% jump in Q4 gross profit and trim its burdensome debt stack.

Investing & Commentary#

The geopolitical map for biotechnology investments is rapidly shifting as the European pharma sector loses ground to aggressive U.S. pricing policies and a surging Chinese biotech ecosystem. Experts warn that President Trump’s “most-favored-nation” drug pricing and the threat of new tariffs are forcing drugmakers to delay European launches to protect lucrative U.S. margins. On the artificial intelligence front, momentum at the HumanX conference clearly favored Anthropic over OpenAI, with developers swarming to Claude Code for enterprise deployments while closely monitoring the rapid rise of China’s top-tier open-weight models.

Also Worth Watching#

• Elon Musk’s xAI faces fresh opposition after landing permit for Mississippi power plant: Environmental groups are legally challenging a state permit allowing xAI to build a massive methane gas-burning power plant to supply its new Memphis-area data centers.
• OpenAI identifies security issue involving third-party tool, says user data was not accessed: A software supply chain attack linked to North Korea compromised a developer tool used by OpenAI, forcing security certification updates for macOS applications.
• Artemis II astronauts hurtle home from moon toward splashdown: NASA’s Orion capsule successfully returned to Earth after a 10-day lunar flyby, clearing a critical heat shield test and paving the way for future moon landings.
• Judge told to reconsider national security implications of halting Trump’s White House ballroom: An appeals court remanded an injunction halting the $400 million East Wing project, questioning how the stoppage impacts necessary underground security installations.
• Allies yank support for Swalwell’s California governor run after sexual assault allegations: Key backers and labor unions abandoned Rep. Eric Swalwell’s gubernatorial campaign following sexual assault accusations, which he vehemently denies.